Does PONATINIB Cause Thrombophlebitis superficial? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Thrombophlebitis superficial have been filed in association with PONATINIB (Iclusig). This represents 0.1% of all adverse event reports for PONATINIB.
5
Reports of Thrombophlebitis superficial with PONATINIB
0.1%
of all PONATINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Thrombophlebitis superficial From PONATINIB?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Thrombophlebitis superficial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Product dose omission issue (817)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
What Other Drugs Cause Thrombophlebitis superficial?
DROSPIRENONE\ETHINYL ESTRADIOL (160)
LENALIDOMIDE (121)
ETHINYL ESTRADIOL\ETONOGESTREL (93)
RIVAROXABAN (82)
YAZ (78)
YASMIN (65)
TESTOSTERONE (62)
HUMAN IMMUNOGLOBULIN G (43)
ADALIMUMAB (40)
CAPECITABINE (29)
Which PONATINIB Alternatives Have Lower Thrombophlebitis superficial Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE